Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: OPC Pharmaceutical

Market Cap 1,531B 58.29M 50.24M 46.24M 43.38M 81.49M 5.51B 82.3M 547M 214M 2.7B 219M 214M 9.34B P/E Ratio 2024
17.6x
P/E Ratio 2025 15.6x
Enterprise Value 1,212B 46.14M 39.77M 36.6M 34.34M 64.5M 4.36B 65.14M 433M 169M 2.14B 173M 169M 7.39B EV / Sales 2024
1.4x
EV / Sales 2025 1.08x
Free-Float
57.32%
Yield 2024 *
-
Yield 2025 -
04-29 Opc Pharmaceutical Joint Stock Company Announces Board Changes, Effective April 25, 2026 CI
04-28 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-06 OPC Pharmaceutical Joint Stock Company announces Annual dividend, payable on July 20, 2026 CI
01-30 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
26/10/25 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
24/07/25 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
28/04/25 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
24/01/25 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
23/10/24 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
30/07/24 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
13/05/24 Opc Pharmaceutical Joint Stock Company Appoints Nong Thi Lan as Member of the Internal Audit Committee CI
06/05/24 OPC Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2023, Payable on May 21, 2024 CI
02/05/24 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
1 week+2.58%
Current month+2.58%
1 month+2.58%
3 months+8.39%
6 months+5.75%
Current year-0.42%
1 week 23,900
Extreme 23900
23,900
1 month 21,700
Extreme 21700
24,900
Current year 21,700
Extreme 21700
24,900
1 year 21,100
Extreme 21100
25,400
3 years 21,000
Extreme 21000
27,000
5 years 21,000
Extreme 21000
30,700
10 years 14,190.87
Extreme 14190.8714
30,700
Manager TitleAgeSince
Chief Executive Officer 60 14/07/2021
Chief Administrative Officer - -
Chief Tech/Sci/R&D Officer 56 02/05/2011
Director TitleAgeSince
Chairman 70 01/04/2011
Chairman - 22/10/2021
Director/Board Member 50 22/10/2021
Date Insider Type Main position Quantity % Market Cap.
05/08/24Sell

Controller/Auditor

200,000 0.3123%
07/03/24Buy 8,584,829 13.4031%
18/12/23Sell 11,134,200 17.3834%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.58%+0.84%+3.24% 58.31M
-0.32%-1.72%+37.83%+148.79% 1,010B
-2.16%+1.51%+50.01%+43.93% 580B
-2.70%-0.66%+15.97%+63.07% 402B
-1.18%+1.05%+20.91%+18.37% 330B
-1.52%+2.45%+23.73%+33.03% 281B
-1.95%-4.32%+20.15%+12.96% 280B
-0.57%+5.00%-44.67%-48.28% 197B
-1.31%+1.39%+18.74%+53.45% 192B
-0.38%-2.97%+13.02%+57.34% 156B
Average -1.12%-0.36%+15.65%+38.59% 342.88B
Weighted average by Cap. -1.03%-0.16%+26.15%+67.03%

Financials

2024 2025
Net sales 969B 36.88M 31.79M 29.26M 27.45M 51.56M 3.49B 52.07M 346M 135M 1.71B 138M 135M 5.91B 1,123B 42.76M 36.86M 33.92M 31.82M 59.78M 4.04B 60.37M 401M 157M 1.98B 160M 157M 6.85B
Net income 107B 4.08M 3.51M 3.23M 3.03M 5.7M 385M 5.76M 38.23M 14.93M 189M 15.3M 14.98M 653M 116B 4.41M 3.8M 3.5M 3.28M 6.17M 417M 6.23M 41.38M 16.16M 204M 16.56M 16.21M 707M
Net Debt -247B -9.42M -8.12M -7.47M -7.01M -13.16M -890M -13.29M -88.31M -34.49M -436M -35.34M -34.59M -1.51B -319B -12.15M -10.48M -9.64M -9.04M -16.99M -1.15B -17.16M -114M -44.52M -563M -45.61M -44.64M -1.95B
Logo OPC Pharmaceutical
OPC Pharmaceutical Joint-Stock Company (OPC) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets drugs and other medical products from natural pharmaceutical materials which are cultivated and processed at the facilities of the Company. It is also involved in the production and wholesale trading of pharmaceutical chemicals and supplies, as well as functional food. Moreover, the Company is involved in wine distillery and bottled water manufacturing. On June 13, 2014, the Company announced that it has dissolved its joint venture named OPC EXIM Real Estate Joint Stock Company.
Employees
871
Date Price Change Volume
10/06/26 23,900.00 0.00% 1,010
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!